Department of Biochemistry, Cancer Biology, Neuroscience and Pharmacology, Meharry Medical College, Nashville, TN, USA.
Department of Internal Medicine, Meharry Medical College, Nashville, TN, USA.
FEBS Lett. 2018 Oct;592(19):3274-3285. doi: 10.1002/1873-3468.13236. Epub 2018 Sep 20.
The mechanisms by which exosomes (nano-vesicular messengers of cells) are taken up by recipient cells are poorly understood. We hypothesized that histones associated with these nanoparticles are the ligands which facilitate their interaction with cell surface syndecan-4 (SDC4) to mediate their uptake. We show that the incubation with fetuin-A (exosome-associated proteins) and histones mediates the uptake of exosomes that are normally not endocytosed. Similarly, hydroxyapatite-nanoparticles incubated with fetuin-A and histones (FNH) are internalized by tumor cells, while nanoparticles incubated with fetuin-A alone (FN) are not. The uptake of exosomes and FNH, both of which move to the perinuclear region of the cell, is attenuated in SDC4-knockdown cells. Data show that FNH can compete with exosomes for uptake and that both use SDC4 as uptake receptors.
外泌体(细胞的纳米囊泡信使)被受体细胞摄取的机制尚不清楚。我们假设与这些纳米颗粒相关的组蛋白是配体,它们促进与细胞表面 syndecan-4(SDC4)的相互作用,从而介导其摄取。我们表明,与胎球蛋白 A(外泌体相关蛋白)和组蛋白孵育可介导通常不被内吞的外泌体的摄取。同样,与胎球蛋白 A 和组蛋白孵育的羟基磷灰石纳米颗粒被肿瘤细胞内化,而仅与胎球蛋白 A 孵育的纳米颗粒(FN)则不会。外泌体和 FNH 的摄取都转移到细胞的核周区域,在 SDC4 敲低细胞中被减弱。数据表明,FNH 可以与外泌体竞争摄取,并且两者都使用 SDC4 作为摄取受体。